ZA200905551B - Use of lactobacillus casel for increasing the protection provided by the influenza vaccine - Google Patents

Use of lactobacillus casel for increasing the protection provided by the influenza vaccine

Info

Publication number
ZA200905551B
ZA200905551B ZA200905551A ZA200905551A ZA200905551B ZA 200905551 B ZA200905551 B ZA 200905551B ZA 200905551 A ZA200905551 A ZA 200905551A ZA 200905551 A ZA200905551 A ZA 200905551A ZA 200905551 B ZA200905551 B ZA 200905551B
Authority
ZA
South Africa
Prior art keywords
increasing
influenza vaccine
protection provided
casel
lactobacillus
Prior art date
Application number
ZA200905551A
Other languages
English (en)
Inventor
Sandrine Samson-Villeger
Raphaelle Bourdet-Sicard
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of ZA200905551B publication Critical patent/ZA200905551B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA200905551A 2007-02-16 2009-08-11 Use of lactobacillus casel for increasing the protection provided by the influenza vaccine ZA200905551B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0701140A FR2912657B1 (fr) 2007-02-16 2007-02-16 Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale.

Publications (1)

Publication Number Publication Date
ZA200905551B true ZA200905551B (en) 2010-05-26

Family

ID=38508753

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200905551A ZA200905551B (en) 2007-02-16 2009-08-11 Use of lactobacillus casel for increasing the protection provided by the influenza vaccine

Country Status (16)

Country Link
US (1) US8349315B2 (ru)
EP (1) EP2120590B1 (ru)
JP (1) JP2010518151A (ru)
KR (1) KR20090115960A (ru)
CN (1) CN101918013A (ru)
AR (1) AR065362A1 (ru)
AT (1) ATE530070T1 (ru)
BR (1) BRPI0807649A2 (ru)
CA (1) CA2678004A1 (ru)
ES (1) ES2378052T3 (ru)
FR (1) FR2912657B1 (ru)
MX (1) MX2009008767A (ru)
PL (1) PL2120590T3 (ru)
RU (1) RU2470994C2 (ru)
WO (1) WO2008129148A2 (ru)
ZA (1) ZA200905551B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2937252B1 (fr) * 2008-10-17 2011-05-20 Pf Medicament Association d'un extrait de sureau et d'une souche de l. paracasei.
CN103220921B (zh) * 2010-10-15 2015-12-16 科.汉森有限公司 免疫佐剂
WO2014038929A1 (en) 2012-09-07 2014-03-13 N.V. Nutricia Probiotics for producing antiviral factors
WO2015029967A1 (ja) * 2013-08-26 2015-03-05 株式会社明治 乳酸菌を用いた抗体価上昇剤
WO2018220416A1 (en) * 2017-05-31 2018-12-06 Compagnie Gervais Danone Lactobacillus paracasei strain capable of improving the immune response to a viral-bacterial coinfection
WO2023080070A1 (ja) * 2021-11-02 2023-05-11 株式会社ヤクルト本社 Ｔｃｒクローン数の増強剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
WO2006124630A2 (en) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions and methods for enhancing the efficacy of vaccines

Also Published As

Publication number Publication date
FR2912657A1 (fr) 2008-08-22
WO2008129148A3 (fr) 2009-02-12
PL2120590T3 (pl) 2012-05-31
KR20090115960A (ko) 2009-11-10
BRPI0807649A2 (pt) 2014-06-10
CA2678004A1 (fr) 2008-10-30
EP2120590B1 (fr) 2011-10-26
MX2009008767A (es) 2009-10-12
FR2912657B1 (fr) 2009-04-17
JP2010518151A (ja) 2010-05-27
CN101918013A (zh) 2010-12-15
US20100129334A1 (en) 2010-05-27
RU2470994C2 (ru) 2012-12-27
AR065362A1 (es) 2009-06-03
WO2008129148A2 (fr) 2008-10-30
ES2378052T3 (es) 2012-04-04
ATE530070T1 (de) 2011-11-15
EP2120590A2 (fr) 2009-11-25
RU2009134520A (ru) 2011-03-27
US8349315B2 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
HK1143085A1 (en) Low-additive influenza vaccines
HK1138853A1 (en) Vaccine
IL201782A0 (en) Vaccine
ZA201103175B (en) Vaccine composition for use against influenza
GB0717911D0 (en) Vaccine
ZA201004303B (en) Vaccine
GB0711858D0 (en) Vaccine
EP1998814A4 (en) NEW VACCINES AGAINST INFLUENZA M2
IL213475A0 (en) Assembly for the use of alternative energy
ZA200905551B (en) Use of lactobacillus casel for increasing the protection provided by the influenza vaccine
ZA201100962B (en) Influenza vaccines
PL2482845T3 (pl) Nowa kompozycja szczepionki przeciw grypie
GB0710538D0 (en) Vaccine
ZA201003851B (en) Vaccine
IL202670A0 (en) Intradermal influenza vaccine
GB0709373D0 (en) BCG-based anti-atheroma vaccine
AU2007901868A0 (en) Combination therapy for highly virulent influenza
GB0725121D0 (en) Vaccine
GB0721928D0 (en) Vaccine
GB0711357D0 (en) Vaccine
GB0707697D0 (en) Vaccine
GB0706825D0 (en) Vaccine
GB0706540D0 (en) Anti-atheroma vaccine
GB0724651D0 (en) Vaccine
GB0701262D0 (en) Vaccine